CoChat

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.

Open access

Abstract

Multiple myeloma (MM) is a hematologic malignancy characterized by accumulation of plasma cells in the bone marrow (BM). Bone destruction is a complication of the disease and is usually associated with severe morbidity. The balance between receptor activator of nuclear factor-κB (NF-κB) ligand and osteoprotegerin (OPG) is of major importance in bone homeostasis. We have recently shown that serum OPG levels are lower in patients with myeloma than in healthy individuals. Here we show that myeloma cells can bind, internalize, and degrade OPG, thereby providing a possible explanation for the lower levels of OPG in the BM of patients with MM. This process is dependent on interaction of OPG with heparan sulfates on the myeloma cells. The results suggest a novel biologic mechanism for the bone disease associated with MM and that treatment of the bone disease with OPG lacking the heparin-binding domain should be considered.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2002-04-1190

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Cited by

See all 253

Metadata

Authors
Standal, T., Seidel, C., Hjertner, Ø., Plesner, T., Sanderson, R. D., Waage, A., Borset, M., & Sundan, A.
Affiliations
  • Norwegian University of Science and Technology (NO)
  • From the Institute of Cancer Research and Molecular Biology, Faculty of Medicine, Norwegian University of Science and Technology, Medisinsk Teknisk Senter, Trondheim, Norway; Department of Oncology, Division of Hematology, Vejle Hospital, Vejle, Denmark; and Arkansas Cancer Research Center and Departments of Pathology and Anatomy, University of Arkansas for Medical Science, Little Rock.
Venue
Blood
Published
2002-10-15
Volume
100
Issue
8
Pages
3002-3007
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2030504185
Cited by
244
References
39
Citations by year
2025: 4 · 2024: 3 · 2023: 2 · 2022: 9 · 2021: 11 · 2020: 10 · 2019: 5 · 2018: 7 · 2017: 8 · 2016: 4 · 2015: 5 · 2014: 11 · 2013: 11 · 2012: 5
FWCI
8.29
Type
journal article
Language
en
Licence
other-oa
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion, other-oa)
Funders
  • Sundhed og Sygdom, Det Frie Forskningsråd
  • Kreftforeningen
  • Norges Forskningsråd
  • Medical Research Council
Topics
  • Health Sciences › Medicine › Hematology › Multiple Myeloma Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Health Sciences › Medicine › Oncology › Bone health and treatments
Keywords
osteoprotegerin, multiple myeloma, bone destruction, RANKL, heparan sulfate, bone homeostasis, myeloma bone disease, heparin-binding domain
MeSH terms
Aged, Biodegradation, Environmental, Biological Transport, Biopsy, Bone Marrow Cells, Female, Glycoproteins, Humans, Immunohistochemistry, Male, Multiple Myeloma, Tumor Cells, Cultured, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Microscopy, Confocal, Osteoprotegerin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. https://app.cochat.ai/papers/10.1182/blood-2002-04-1190
The paper
Standal, T., Seidel, C., Hjertner, Ø., Plesner, T., Sanderson, R. D., Waage, A., Borset, M., & Sundan, A. (2002). Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. Blood. https://doi.org/10.1182/blood-2002-04-1190

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.